Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

ClinicalTrials.gov ID: NCT04832425

Public ClinicalTrials.gov record NCT04832425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder

Study identification

NCT ID
NCT04832425
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Praxis Precision Medicines
Industry
Enrollment
216 participants

Conditions and interventions

Interventions

  • PRAX-114 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2021
Primary completion
May 4, 2022
Completion
May 4, 2022
Last update posted
Jul 20, 2022

2021 – 2022

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Praxis Research Site Phoenix Arizona 85012
Praxis Research Site Garden Grove California 92845
Praxis Research Site Lafayette California 94549
Praxis Research Site Lemon Grove California 91945
Praxis Research Site Oceanside California 92056
Praxis Research Site Pico Rivera California 90660
Praxis Research Site Redlands California 92374
Praxis Research Site Jacksonville Florida 32256
Praxis Research Site Orange City Florida 32763
Praxis Research Site Orlando Florida 32801
Praxis Research Site Atlanta Georgia 30331
Praxis Research Site Decatur Georgia 30030
Praxis Research Site Chicago Illinois 60076
Praxis Research Site Gaithersburg Maryland 20877
Praxis Research Site Worcester Massachusetts 01655
Praxis Research Site O'Fallon Missouri 63368
Praxis Research Site Las Vegas Nevada 89102
Praxis Research Site Berlin New Jersey 08009
Praxis Research Site Marlton New Jersey 08053
Praxis Research Site Cedarhurst New York 11516
Praxis Research Site Rochester New York 14618
Praxis Research Site Staten Island New York 10312
Praxis Research Site Dayton Ohio 45417
Praxis Research Site Allentown Pennsylvania 18104
Praxis Research Site Media Pennsylvania 19063
Praxis Research Site Memphis Tennessee 38119
Praxis Research Site Austin Texas 78737
Praxis Research Site San Antonio Texas 78229
Praxis Research Site Charlottesville Virginia 22903
Praxis Research Site Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04832425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04832425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →